false
Catalog
8th Annual Association for Bariatric Endoscopy (AB ...
COVID-19 and Obesity-Management of the Obese Patie ...
COVID-19 and Obesity-Management of the Obese Patient in theCOVID-19 Era
Back to course
Pdf Summary
The COVID-19 pandemic has had a disproportionate impact on patients with obesity. Studies have shown that obesity is a major risk factor for severe illness, ventilator dependency, and increased mortality in COVID-19 patients. Between the beginning of the pandemic and November 18, 2020, over 1 million adult COVID-19 hospitalizations in the US were attributed to obesity. Patients with obesity have a higher rate of ICU admission and death compared to those with normal weight. They also have a shorter time to ICU admission and lower survival probability. The close relationship between obesity and conditions like diabetes, hypertension, and metabolic syndrome may contribute to the increased risk of severe illness.<br /><br />The presence of obesity may also influence the clinical course of COVID-19 patients. Obesity is associated with a higher risk of ICU admission or death even after adjusting for age, race, and troponin levels. The inflammatory response to the virus can lead to complications like acute respiratory distress syndrome, cardiac injury, and thromboembolic disease, which are more severe in the presence of comorbidities like obesity.<br /><br />The COVID-19 pandemic has also led to weight gain in many individuals, with 42% of US adults reporting undesired weight gain since the start of the pandemic. Marginalized groups have been more affected, and pediatric obesity rates have increased. The pandemic has also seen a rise in telemedicine platforms, which has both positive and negative impacts on patient care.<br /><br />The pandemic has had a negative impact on the overall obesity pandemic, with many patients going undiagnosed and untreated due to fear and hospital capacity issues. There has been a backlog in endoscopic bariatric therapies, worsening the obesity crisis. The understanding of the link between COVID-19 and obesity should be used to treat patients with obesity seriously rather than further stigmatizing them. Access to care for obesity treatments, such as endoscopic and surgical interventions, has been affected by the pandemic. Telemedicine has become more prominent and is likely to continue after the pandemic.
Asset Subtitle
Reem Sharaiha, MD
Keywords
COVID-19
pandemic
obesity
severe illness
ventilator dependency
mortality
ICU admission
death
diabetes
hypertension
×
Please select your language
1
English